Skip to main content
. Author manuscript; available in PMC: 2024 Feb 8.
Published in final edited form as: Contemp Clin Trials. 2023 Jul 3;132:107279. doi: 10.1016/j.cct.2023.107279

Table 1.

Inclusion and exclusion criteria for the ADORE trial.

Inclusion criteria
1. Pregnant females 18.0 years and older who are 12 to 20 weeks gestation at study entry
2. Agree to consume study capsules and a typical prenatal supplement of 200 mg DHA
3. Available by telephone
Exclusion criteria
1. <18 years of age at enrollment
2. Expecting multiple infants
3. Gestational age at baseline <12 weeks or > 20 weeks
4. Unable or unwilling to agree to consume capsules until delivery
5. Unwilling to discontinue use of another prenatal supplement with DHA
6. Women with allergy to any component of DHA product (including algae), soybean oil or corn oil